David Peltier


David Peltier joined TheStreet as a research associate in August 2001, and writes TheStreet Stocks Under $10. Before that, Peltier was an analyst for Individual Investor magazine and the publication's Web site. His market interests include small-caps, technology and retail stocks. He has appeared on NPR, NBR and WNYW-TV.

Peltier received his bachelor's degree cum laude in finance and international business from New York University.




A Note From David: My name is David Peltier. I manage a much-followed portfolio for TheStreet called Stocks Under $10 -- the unique investment service that alerts you to what I believe are deeply undervalued stocks with tremendous growth potential.


I've made it my life's work to help investors like you build lasting wealth by investing in only the very best small company stocks.


Because it's these little-known companies, which are overlooked by much of Wall Street, that could break out and double or even triple your money!


Start Your 14-Day Free Trial of Stocks Under $10.


Recent Articles By The Author

Latest Portfolio Earnings and Dividend Reminders

News and updates on seven DSA positions.

TherapeuticsMD Rating Reaffirmed After Earnings

The timeline for its two lead hormone therapy treatments remains on pace.

Kohl's Hikes Quarterly Dividend

Investors at the close of trading on March 3 will qualify for the payment on March 22.

Adding a Health Care Name to Bullpen

Business prospects are improving for Cogentix Medical.

Toll Brothers and Luminex Initiate Dividends

In each case, the start of cash payouts follows better-than-expected quarterly results.